Pharmaceutical Excipients Market to Witness Significant Growth by 2030

[150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global pharmaceutical excipients market was valued at around USD 8.85 billion in 2021 and is expected to register revenues worth USD 14.2 billion by the end of 2030, growing at an exceptional CAGR of approximately 5.39% between 2022 and 2030.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1761

Pharmaceutical Excipients Market Report Scope

A recent study by Precedence Research on the pharmaceutical excipients market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the pharmaceutical excipients market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of pharmaceutical excipients. The study also provides the dynamics that are responsible for influencing the future status of the pharmaceutical excipients market over the forecast period.

A detailed assessment of the pharmaceutical excipients market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the pharmaceutical excipients market along with their product portfolio enhances the reliability of this comprehensive research study.

Competition Landscape

The report has engulfed a chapter on the global electric vehicle market’s competitive landscape, which provides detailed analysis and insights on companies offering electric vehicle. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.

This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.

Read Also@ Engineering Services Outsourcing Market to Witness Significant Growth by 2030

some of the prominent players in the pharmaceutical excipients market include:

• Ashland Global Holdings
• BASF SE
• DuPont
• Roquette Feres
• Evonik Industries AG
• Associated British Foods
• Archer Daniels Midland Company
• Lubrizol Corporation
• Croda International
• Kerry Group

Pharmaceutical Excipients Market Segments

• Ashland Global Holdings
• BASF SE
• DuPont
• Roquette Feres
• Evonik Industries AG
• Associated British Foods
• Archer Daniels Midland Company
• Lubrizol Corporation
• Croda International
• Kerry Group

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global pharmaceutical excipients market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the pharmaceutical excipients market.

The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.

Why should you invest in this report?

If you are aiming to enter the global pharmaceutical excipients market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmaceutical excipients are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmaceutical Excipients Market 

5.1. COVID-19 Landscape: Pharmaceutical Excipients Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmaceutical Excipients Market, By Product

8.1. Pharmaceutical Excipients Market, by Product, 2022-2030

8.1.1. Organic Chemicals

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Inorganic Chemicals

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Pharmaceutical Excipients Market, By Functionality

9.1. Pharmaceutical Excipients Market, by Functionality, 2022-2030

9.1.1. Fillers and Diluents

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Suspending and Viscosity Agents

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Coating Agents

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Binders

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Disintegrants

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Colorants

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Lubricants and Glidants

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Preservatives

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Emulsifying Agents

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Flavoring Agents and Sweeteners

9.1.10.1. Market Revenue and Forecast (2017-2030)

9.1.11. Other Functionalities

9.1.11.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Pharmaceutical Excipients Market, By Formulations 

10.1. Pharmaceutical Excipients Market, by Formulations, 2022-2030

10.1.1. Topical Formulations

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Oral Formulations

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Parenteral Formulations

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.3. Other Formulations

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Pharmaceutical Excipients Market, By End-Users

11.1. Pharmaceutical Excipients Market, by End-Users, 2022-2030

11.1.1. Pharmaceuticals Companies

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Research Organization

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Academics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Other

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Pharmaceutical Excipients Market, By Distribution Channel

12.1. Pharmaceutical Excipients Market, by Distribution Channel, 2022-2030

12.1.1. Online Pharmacy

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Retail

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Mail-Order

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Pharmaceutical Excipients Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.1.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.1.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.1.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.1.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.1.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.7. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.10. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.12.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.14.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.15. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.10.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.11.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.10.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.11.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.5.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.5.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.5.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 14. Company Profiles

14.1. Ashland Global Holdings

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. BASF SE

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. DuPont

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Roquette Feres

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Evonik Industries AG

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Associated British Foods

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Archer Daniels Midland Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Lubrizol Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Croda International

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Kerry Group

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1761

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com